Welcome to our dedicated page for Cadre Holdings SEC filings (Ticker: CDRE), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Our SEC filing database is enhanced with expert analysis from Rhea-AI, providing insights into the potential impact of each filing on Cadre Holdings's stock performance. Each filing includes a concise AI-generated summary, sentiment and impact scores, and end-of-day stock performance data showing the actual market reaction. Navigate easily through different filing types including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, proxy statements (DEF 14A), and Form 4 insider trading disclosures.
Designed for fundamental investors and regulatory compliance professionals, our page simplifies access to critical SEC filings. By combining real-time EDGAR feed updates, Rhea-AI's analytical insights, and historical stock performance data, we provide comprehensive visibility into Cadre Holdings's regulatory disclosures and financial reporting.
Cadre Holdings, Inc. reported results of its 2026 Annual Meeting of Stockholders held on May 29, 2026. The terms of directors Gianmaria C. Delzanno and Deborah A. DeCotis expired, and they were not nominated for re-election; the company states this was not due to any disagreement.
Stockholder participation was high, with 40,406,208 of 42,797,451 shares of Common Stock present or represented by proxy and entitled to vote, representing approximately 94.41% of shares entitled to vote. Shareholders elected five directors — Warren B. Kanders, William Quigley, Hamish Norton, Nicholas Sokolow, and Mary Kissel — and ratified KPMG LLP as independent registered public accounting firm for the year ending December 31, 2026.
Cadre Holdings, Inc. director Mary E. Kissel has filed an initial Form 3 reporting her beneficial ownership of the company’s common stock. The filing lists 0 shares of Common Stock, $0.0001 par value per share, held directly as of the reported date, and does not show any buy or sell transactions.
Cadre Holdings, Inc. director Nicolas Sokolow filed an initial Form 3 reporting his ownership of the company’s common stock. The filing shows indirect holdings of 69,231 shares through ST Investors Fund, LLC, 224,000 shares through Korsak Holdings, LLC, and 317,567 shares through Madetys Investments, LLC, plus 40,347 shares held directly.
The indirect positions are owned by the respective LLCs, and Sokolow disclaims beneficial ownership of those securities except to the extent of his pecuniary interest in them.
Cadre Holdings, Inc. filing an Amendment No. 1 to a Schedule 13G/A reports that Capital International Investors (CII) beneficially owns 1,260,806 shares of Common Stock, equal to 3.0% of the 42,726,564 shares believed outstanding as shown in the filing. The filing lists CII's sole voting and dispositive power over the 1,260,806 shares. The signature block shows the amendment was signed on 05/13/2026.
Cadre Holdings reported higher sales but sharply lower profit for the quarter ended March 31, 2026. Net sales rose to $155.4 million from $130.1 million, driven mainly by recent acquisitions, including TYR Tactical, which added new product lines and customers.
Despite this 19.5% sales increase, net income fell to $2.0 million from $9.2 million. Profit was pressured by higher manufacturing costs, inventory step-up amortization, increased compensation, transaction and related party expenses tied to acquisitions, and higher interest expense from additional debt. Adjusted EBITDA was relatively stable at $21.1 million versus $20.5 million.
Cadre used significant cash for acquisitions, reducing cash and cash equivalents to $41.3 million, while total debt rose to $365.8 million (gross). Orders backlog increased to $355.4 million, reflecting strong demand in explosive ordnance disposal, TYR products, nuclear safety solutions and duty gear.
Cadre Holdings reported mixed first quarter 2026 results. Net sales rose to $155.4 million, up 19% year-over-year, driven mainly by recent acquisitions, while gross profit increased modestly to $60.2 million. However, gross margin declined to 38.7% from 43.1% and net income fell sharply to $2.0 million from $9.2 million as higher compensation, interest, transaction and related party expenses weighed on earnings.
Adjusted EBITDA edged up to $21.1 million, with margin compressing to 13.6% from 15.8%. The company highlighted a record $355 million orders backlog, up $166 million since the start of the year, helped by the blast attenuation seat contract and the TYR acquisition. Cadre closed acquisitions of TYR Tactical and Alien Gear Holsters and reaffirmed 2026 guidance for net sales of $736–$758 million and adjusted EBITDA of $136–$141 million, while declaring a quarterly dividend of $0.10 per share.
Cadre Holdings Inc. ownership disclosure: FMR LLC reports beneficial ownership of 3,319,196.11 shares of Common Stock, representing 7.8% of the class as of 03/31/2026, in an amended Schedule 13G/A filing. The filing names Abigail P. Johnson as having sole dispositive power and references an exhibit for subsidiary identification.
Cadre Holdings, Inc. is asking stockholders to vote at a fully virtual annual meeting on May 29, 2026. Investors will elect five directors, including two new nominees, and ratify KPMG LLP as independent auditor for 2026. Only holders of 42,797,451 shares outstanding as of April 7, 2026 may vote.
The proxy details governance practices, director independence and committee structures, with a majority-independent board and NYSE-aligned policies. It also discloses significant insider ownership, led by CEO Warren B. Kanders at 27.1%, and outlines 2025 executive pay, including bonuses tied to adjusted EBITDA and recent acquisitions.
Cadre Holdings, Inc. president Brad Williams received new equity awards as part of his compensation. He was granted 18,399 restricted stock units tied to Cadre common stock, which will vest in three equal installments of 6,133 shares on March 30 of 2027, 2028, and 2029.
Williams also received stock options for 59,597 shares at an exercise price of $29.39 per share, expiring on March 30, 2036. These options vest in three tranches: 19,867 shares on March 30, 2027, and 19,865 shares on each of March 30, 2028 and 2029.